Duty-cycled Multi-electrode Radiofrequency Vs. Conventional Irrigated Point-by-point Radiofrequency Ablation for Recurrent Atrial Fibrillation: Comparative 3-year Data
Overview
Physiology
Affiliations
Aims: Pulmonary vein isolation (PVI) is an accepted treatment to relieve symptoms in patients with atrial fibrillation (AF). We studied 3 year outcome after PVI guided by duty-cycled multi-electrode radiofrequency (RF) ablation (pulmonary vein ablation catheter, PVAC) and provided comparative data to outcome after conventional PVI (CPVI) using mapping with irrigated, point-per-point RF ablation.
Methods And Results: One hundred and sixty-one consecutive patients with symptomatic paroxysmal or persistent AF and minimal heart disease underwent PVI (PVAC, n = 79 vs. CPVI, n = 82). Follow-up (with symptom-guided rhythm monitoring) was truncated at 3 years in all patients. Success was defined as freedom of documented arrhythmia after a single procedure and without antiarrhythmic drug treatment (ADT). Baseline characteristics did not differ between both groups. At 3 years follow-up, single-procedure success without ADT was comparable between PVAC and CPVI (65% vs. 55%, P = NS). The majority of recurrences occurred during the first year (PVAC 79% vs. CPVI 70%, P = NS). The annual rate of very late recurrence (i.e. beyond 1 year) was similar in both groups (10.5% vs. 15%, P = NS).
Conclusion: At 3 years follow-up, outcome after PVAC-guided PVI is comparable to conventional isolation by irrigated point-by-point RF ablation. In both strategies, the majority of recurrences occurred in the first year of ablation.
Emerging Tools and Techniques for Catheter Ablation of Cardiac Arrhythmias: A 2024 Update.
Aryana A, dAvila A J Innov Card Rhythm Manag. 2024; 15(1):5718-5727.
PMID: 38304094 PMC: 10829418. DOI: 10.19102/icrm.2024.15019.
Bisbal F, Abugattas J, Trotta O, Gonzalez-Ferrer J, Sauri-Ortiz A, Angel Arias M Heart Rhythm O2. 2023; 3(6Part A):656-664.
PMID: 36589911 PMC: 9795263. DOI: 10.1016/j.hroo.2022.07.013.
Catheter Ablation of Atrial Fibrillation: A Review of the Current Status and Future Directions.
Melby D J Innov Card Rhythm Manag. 2020; 8(11):2907-2917.
PMID: 32477760 PMC: 7252758. DOI: 10.19102/icrm.2017.081101.
Kozluk E, Piatkowska A, Rodkiewicz D, Peller M, Kochanowski J, Opolski G Arch Med Sci. 2019; 15(1):78-85.
PMID: 30697256 PMC: 6348353. DOI: 10.5114/aoms.2017.68054.
Siebermair J, Silver M, Wakili R J Atr Fibrillation. 2017; 9(6):1600.
PMID: 29250297 PMC: 5673347. DOI: 10.4022/jafib.1600.